{"favorite_id": 10108, "calc_type": "calculator", "dosing": false, "full_title_en": "FIGO Staging for Ovarian Cancer (2014)", "short_title_en": "FIGO Staging for Ovarian Cancer", "medium_description_en": "<span id=\"docs-internal-guid-a838d9f6-7fff-a3cd-3b55-f3aa70899bd0\">Stages cancer of the ovary, fallopian tube, and peritoneum.</span>", "short_description_en": "Ovarian CA staging.", "before_use": "", "instructions_en": "", "purpose_en": ["Diagnosis"], "disease_en": ["Ovarian Cancer"], "specialty_en": ["OB-Gyn", "Internal Medicine", "Hospitalist Medicine", "Hematology and Oncology", "Radiology", "Radiation Oncology", "Gastroenterology"], "chief_complaint_en": ["Abdominal Pain", "Nausea", "Fatigue", "Weight Loss/Gain", "Cancer"], "system_en": ["Reproductive", "Oncologic"], "search_abbreviation_en": ["fallopian tube", "peritoneum", "ovary", "ovaries", "mass"], "slug": "figo-staging-ovarian-cancer-2014", "seo": {"meta_description_en": "The FIGO Staging for Ovarian Cancer (2014) stages cancer of the ovary, fallopian tube, and peritoneum.", "keywords_en": "Tnm staging for ovarian cancer, tnm, tnm staging, fallopian tube, peritoneum, ovary, ovaries"}, "content": {"how_to_use": {"use_case_en": "<p><span id=\"docs-internal-guid-ad9562c6-7fff-d99b-32a6-5636292a931e\">Use postoperatively in patients with histologically-proven ovarian cancer (surgical pathology is needed in order to stage).</span></p>", "pearls_pitfalls_en": "<p><span id=\"docs-internal-guid-88219c43-7fff-0d41-37a6-a7d3def3d08f\"></span></p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Stage IB (bilateral involvement) is uncommon and only occurs in 1-5% of stage I cases (<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/17161157\" target=\"_blank\">Heintz 2006</a>). Large stage IB ovarian tumors associated with a contralateral normal\u2010size ovary with small superficial tumor foci suggest the latter are metastatic (\u2153 of stage I tumors with bilateral involvement look like this) (<a href=\"https://obgyn.onlinelibrary.wiley.com/doi/full/10.1016/j.ijgo.2013.10.001\" target=\"_blank\">Prat 2013</a>).</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Controversy exists around whether positive lymph nodes (macroscopic) above the renal vessels should be considered stage III or IV, and are not addressed by the current guidelines.</p>\n</li>\n</ul>", "why_use_en": ""}, "next_steps": {"advice_en": "<p><span id=\"docs-internal-guid-a4af50a3-7fff-a04f-08d2-6511ee52932c\">Treat according to stage and consideration for patient preferences.</span></p>", "management_en": "", "critical_actions_en": ""}, "about": {"formula_en": "<p></p>\n<div dir=\"ltr\">\n<table><colgroup><col width=\"*\" /><col width=\"*\" /><col width=\"*\" /><col width=\"*\" /></colgroup>\n<tbody>\n<tr>\n<td colspan=\"4\">\n<p dir=\"ltr\"><strong>Stage I: Tumor confined to ovaries</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">IA</p>\n</td>\n<td colspan=\"3\">\n<p dir=\"ltr\">Tumor limited to 1 ovary, capsule intact, no tumor on surface, negative washings</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">IB</p>\n</td>\n<td colspan=\"3\">\n<p dir=\"ltr\">Tumor involves both ovaries otherwise like IA</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"4\">\n<p dir=\"ltr\">IC</p>\n</td>\n<td colspan=\"3\">\n<p dir=\"ltr\">Tumor limited to 1 or both ovaries</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">IC1</p>\n</td>\n<td colspan=\"2\">\n<p dir=\"ltr\">Surgical spill</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">IC2</p>\n</td>\n<td colspan=\"2\">\n<p dir=\"ltr\">Capsule rupture before surgery or tumor on ovarian surface</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">IC3</p>\n</td>\n<td colspan=\"2\">\n<p dir=\"ltr\">Malignant cells in the ascites or peritoneal washings</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\">\n<p dir=\"ltr\"><strong>Stage II: Tumor involves 1 or both ovaries with pelvic extension (below the pelvic brim) or primary peritoneal cancer</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">IIA</p>\n</td>\n<td colspan=\"3\">\n<p dir=\"ltr\">Extension and/or implant on uterus and/or fallopian tubes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">IIB</p>\n</td>\n<td colspan=\"3\">\n<p dir=\"ltr\">Extension to other pelvic intraperitoneal tissues</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\">\n<p dir=\"ltr\"><strong>Stage III: Tumor involves 1 or both ovaries with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes</strong></p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"5\">\n<p dir=\"ltr\">IIIA</p>\n</td>\n<td colspan=\"3\">\n<p dir=\"ltr\">Positive retroperitoneal lymph nodes and/or microscopic metastasis beyond the pelvis</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"3\">\n<p dir=\"ltr\">IIIA1</p>\n</td>\n<td colspan=\"2\">\n<p dir=\"ltr\">Positive retroperitoneal lymph nodes only</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">IIIA1(i)</p>\n</td>\n<td>\n<p dir=\"ltr\">Metastasis &le;10 mm</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">IIIA1(ii)</p>\n</td>\n<td>\n<p dir=\"ltr\">Metastasis &gt;10 mm</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">IIIA2</p>\n</td>\n<td colspan=\"2\">\n<p dir=\"ltr\">Microscopic, extrapelvic (above the brim) peritoneal involvement &plusmn; positive retroperitoneal lymph nodes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">IIIB</p>\n</td>\n<td colspan=\"3\">\n<p dir=\"ltr\">Macroscopic, extrapelvic, peritoneal metastasis &le;2 cm &plusmn; positive retroperitoneal lymph nodes; includes extension to capsule of liver/spleen</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">IIIC</p>\n</td>\n<td colspan=\"3\">\n<p dir=\"ltr\">Macroscopic, extrapelvic, peritoneal metastasis &gt;2 cm &plusmn; positive retroperitoneal lymph nodes; includes extension to capsule of liver/spleen</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\">\n<p dir=\"ltr\"><strong>Stage IV: Distant metastasis excluding peritoneal metastasis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">IVA</p>\n</td>\n<td colspan=\"3\">\n<p dir=\"ltr\">Pleural effusion with positive cytology</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">IVB</p>\n</td>\n<td colspan=\"3\">\n<p dir=\"ltr\">Hepatic and/or splenic parenchymal metastasis, metastasis to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside of the abdominal cavity)</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>\n<p></p>", "more_info_en": "", "evidence_based_medicine_en": "", "references_list": {"Original/Primary Reference": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/24219974", "text": "Prat J. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2014;124(1):1-5."}], "Other References": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/17161157", "text": "Heintz AP, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95 Suppl 1:S161-92."}], "Validation": [{"href": "", "text": ""}], "Clinical Practice Guidelines": [{"href": "", "text": ""}], "Manufacturer Website": [{"href": "", "text": ""}], "Outcomes": [{"href": "", "text": ""}]}}, "contributor": {"expert_name": []}, "creator": [{"name": "Dr. Jaime Prat", "creator_info": {"about_en": "Jaime Prat, MD, is an honorary professor at Autonomous University of Barcelona and a senior consultant in pathology at Hospital Sant Pau in Barcelona, Spain. He is also a member of the World Health Organization (WHO) Committee for Classification of Tumors of the Female Genital Tract and the International Federation of Obstetricians and Gynecologists (FIGO). Dr. Prat\u2019s primary research is focused on gynecologic oncology.", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-jaime-prat.jpg", "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=Prat+J%5Bau%5D"}}], "related_resources": {"mdcalc_rating": {"evidence": "", "clinical": "", "popularity": ""}, "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"type": "radio", "label_en": "Tumor location", "name": "location", "options": [{"label": "Tumor confined to ovaries", "value": 0}, {"label": "Tumor involves 1 or both ovaries with pelvic extension (below the pelvic brim) or primary peritoneal cancer", "value": 1}, {"label": "Tumor involves 1 or both ovaries with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes", "value": 2}, {"label": "Distant metastasis excluding peritoneal metastasis", "value": 3}], "conditionality": "", "show_points": false, "optional": false}, {"type": "radio", "label_en": "Tumor confined to ovaries", "name": "ovaries", "options": [{"label": "Tumor limited to 1 ovary, capsule intact, no tumor on surface, negative washings", "value": 0}, {"label": "Tumor involves both ovaries otherwise like above", "value": 1}, {"label": "Tumor limited to 1 or both ovaries", "value": 2}], "conditionality": "location == 0", "show_points": false, "optional": false}, {"type": "radio", "label_en": "Tumor limited to 1 or both ovaries", "name": "limited", "options": [{"label": "Surgical spill", "value": 0}, {"label": "Capsule rupture before surgery or tumor on ovarian surface", "value": 1}, {"label": "Malignant cells in the ascites or peritoneal washings", "value": 2}], "conditionality": "ovaries == 2", "show_points": false, "optional": false}, {"type": "radio", "label_en": "Tumor involves 1 or both ovaries with pelvic extension (below the pelvic brim) or primary peritoneal cancer", "name": "extension", "options": [{"label": "Extension and/or implant on uterus and/or fallopian tubes", "value": 0}, {"label": "Extension to other pelvic intraperitoneal tissues", "value": 1}], "conditionality": "location == 1", "show_points": false, "optional": false}, {"type": "radio", "label_en": "Tumor involves 1 or both ovaries with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes", "name": "spread", "options": [{"label": "Positive retroperitoneal lymph nodes and/or microscopic metastasis beyond the pelvis", "value": 0}, {"label": "Macroscopic, extrapelvic, peritoneal metastasis \u22642 cm \u00b1 positive retroperitoneal lymph nodes; includes extension to capsule of liver/spleen", "value": 1}, {"label": "Macroscopic, extrapelvic, peritoneal metastasis >2 cm \u00b1 positive retroperitoneal lymph nodes; includes extension to capsule of liver/spleen", "value": 2}], "conditionality": "location == 2", "show_points": false, "optional": false}, {"type": "radio", "label_en": "Positive retroperitoneal lymph nodes and/or microscopic metastasis beyond the pelvis", "name": "lymph", "options": [{"label": "Positive retroperitoneal lymph nodes only", "value": 0}, {"label": "Microscopic, extrapelvic (above the brim) peritoneal involvement \u00b1 positive retroperitoneal lymph nodes", "value": 1}], "conditionality": "spread == 0", "show_points": false, "optional": false}, {"type": "radio", "label_en": "Metastasis", "name": "metastasis", "options": [{"label": "Metastasis \u226410 mm ", "value": 0}, {"label": "Metastasis >10 mm", "value": 1}], "conditionality": "lymph == 0", "show_points": false, "optional": false}, {"type": "radio", "label_en": "Distant metastasis excluding peritoneal metastasis", "name": "distant", "options": [{"label": "Pleural effusion with positive cytology", "value": 0}, {"label": "Hepatic and/or splenic parenchymal metastasis, metastasis to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside of the abdominal cavity)", "value": 1}], "conditionality": "location == 3", "show_points": false, "optional": false}], "md5": "4645f5c80c4026e7394c911e8bcef083", "related_calcs": [{"calcId": 10103, "short_title_en": "RMI for Ovarian Cancer", "slug": "risk-malignancy-index-rmi-ovarian-cancer"}, {"calcId": 29, "short_title_en": "BMI & BSA", "slug": "body-mass-index-bmi-and-body-surface-area-bsa"}, {"calcId": 10054, "short_title_en": "Rai Staging for CLL", "slug": "rai-staging-system-chronic-lymphocytic-leukemia-cll"}]}